SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/10/23 Iovance Biotherapeutics, Inc. 424B5 1:581K Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 424B5 Prospectus - Primary Offering or Shelf Securities HTML 488K - New Facts or Events
tm2320915-1_424b5 - none - 5.3594077s |
| | |
PER SHARE
|
| |
TOTAL
|
| ||||||
Public offering price
|
| | | $ | | | | | $ | | | ||
Underwriting discounts and commissions(1)
|
| | | $ | | | | | $ | | | ||
Proceeds to Iovance Biotherapeutics, Inc. before expenses
|
| | | $ | | | | | $ | | | |
| Goldman Sachs & Co. LLC | | |
Jefferies
|
|
| | |
Page
|
| |||
Prospectus Supplement | | | | | | | |
| | | | S-ii | | | |
| | | | S-iii | | | |
| | | | S-1 | | | |
| | | | S-5 | | | |
| | | | S-7 | | | |
| | | | S-8 | | | |
| | | | S-12 | | | |
| | | | S-19 | | | |
| | | | S-19 | | | |
| | | | S-19 | | | |
| | | | S-20 | | |
| Prospectus | | | | | | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 8 | | | |
| | | | | 9 | | | |
| | | | | 12 | | | |
| | | | | 20 | | | |
| | | | | 21 | | | |
| | | | | 22 | | | |
| | | | | 24 | | | |
| | | | | 26 | | | |
| | | | | 26 | | | |
| | | | | 26 | | | |
| | | | | 27 | | |
UNDERWRITER
|
| |
NUMBER OF
SHARES |
|
Goldman Sachs & Co. LLC
|
| |
|
|
Jefferies LLC
|
| | | |
Total
|
| | | |
| | |
PER SHARE
|
| |
TOTAL
|
| ||||||||||||||||||
| | |
WITHOUT
OPTION TO PURCHASE ADDITIONAL SHARES |
| |
WITH
OPTION TO PURCHASE ADDITIONAL SHARES |
| |
WITHOUT
OPTION TO PURCHASE ADDITIONAL SHARES |
| |
WITH
OPTION TO PURCHASE ADDITIONAL SHARES |
| ||||||||||||
Public offering price
|
| | | $ | | | | | $ | | | | | $ | | | | | $ | | | ||||
Underwriting discounts and commissions paid by us
|
| | | $ | | | | | $ | | | | | $ | | | | | $ | | | ||||
Proceeds to us, before expenses
|
| | | $ | | | | | $ | | | | | $ | | | | | $ | | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 3 | | | |
| | | | 4 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 8 | | | |
| | | | 9 | | | |
| | | | 12 | | | |
| | | | 20 | | | |
| | | | 21 | | | |
| | | | 22 | | | |
| | | | 24 | | | |
| | | | 26 | | | |
| | | | 26 | | | |
| | | | 26 | | | |
| | | | 27 | | |
This ‘424B5’ Filing | Date | Other Filings | ||
---|---|---|---|---|
11/25/23 | ||||
Filed on: | 7/10/23 | 8-K | ||
7/7/23 | ||||
6/30/23 | ||||
6/16/23 | 424B5, 8-K, S-3ASR | |||
6/14/23 | ||||
6/2/23 | 8-K/A | |||
5/18/23 | 8-K, 8-K/A | |||
3/31/23 | 10-Q | |||
1/23/23 | 8-K, 8-K/A | |||
12/31/22 | 10-K, ARS | |||
12/31/21 | 10-K, 5 | |||
12/31/20 | 10-K | |||
1/1/19 | ||||
List all Filings |